High-dose melphalan allows durable engraftment of allogeneic bone marrow.

van Besien, K; Demuynck, H; Lemaistre, C F; Bogaerts, M A; Champlin, R

van Besien, K; Demuynck, H; Lemaistre, C F; Bogaerts, M A; Champlin, R.

Affiliation

van Besien K; University of Texas MD Anderson Cancer Center, Houston, USA.

Bone Marrow Transplant ; 15(2): 321-3, 1995 Feb.

Article in En | MEDLINE | ID: mdl-7773226

Subject(s)

Bone Marrow Transplantation; Graft Rejection/prevention & control; Hodgkin Disease/surgery; Melphalan/administration & dosage; Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery; Adult; Female; Hodgkin Disease/mortality; Humans; Male

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Hodgkin Disease / Bone Marrow Transplantation / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Graft Rejection / Melphalan Limits: Adult / Female / Humans / Male Language: En Journal: Bone Marrow Transplant Year: 1995 Document type: Article

Search on Google

XML

PubMed Links